Biotage AB (publ) (FRA:PQX1)

Market Cap	1.02B
Revenue (ttm)	180.75M
Net Income (ttm)	23.50M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	43.27
Forward PE	59.70
Dividend	0.15 (1.21%)
Ex-Dividend Date	Apr 25, 2025

Volume	500
Average Volume	325
Open	12.50
Previous Close	12.79
Day's Range	12.50 - 12.50
52-Week Range	7.51 - 17.33
Beta	n/a
RSI	50.19
Earnings Date	Aug 6, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal and supported scavengers and reagents, as well as accessories and spare parts...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 680
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PQX1

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.

Financial numbers in SEK